Group One Trading, L.P. Nektar Therapeutics Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Nektar Therapeutics stock. As of the latest transaction made, Group One Trading, L.P. holds 29,738 shares of NKTR stock, worth $34,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,738

Previous 19,460 52.82%

Holding current value

$34,793

Previous $18,000 100.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.9 - $1.83 $9,250 - $18,808	10,278 Added 52.82%	29,738 $36,000
Q1 2024 May 10, 2024	BUY	$0.49 - $0.96 $9,535 - $18,681	19,460 New	19,460 $18,000
Q1 2022 May 12, 2022	SELL	$4.16 - $13.72 $643,331 - $2.12 Million	-154,647 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.83 - $18.41 $65,250 - $110,920	6,025 Added 4.05%	154,647 $2.09 Million
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $188,181 - $271,258	14,398 Added 10.73%	148,622 $2.67 Million
Q2 2021 Aug 10, 2021	SELL	$16.52 - $20.4 $198,107 - $244,636	-11,992 Reduced 8.2%	134,224 $2.3 Million
Q1 2021 May 12, 2021	SELL	$16.56 - $25.46 $101,943 - $156,731	-6,156 Reduced 4.04%	146,216 $2.92 Million
Q4 2020 Feb 10, 2021	BUY	$15.77 - $19.03 $85,284 - $102,914	5,408 Added 3.68%	152,372 $2.59 Million
Q3 2020 Nov 12, 2020	SELL	$16.59 - $24.79 $149,326 - $223,134	-9,001 Reduced 5.77%	146,964 $2.44 Million
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $553,699 - $769,793	32,841 Added 26.67%	155,965 $3.61 Million
Q1 2020 May 13, 2020	SELL	$14.47 - $27.96 $2.79 Million - $5.39 Million	-192,604 Reduced 61.0%	123,124 $2.2 Million
Q4 2019 Feb 10, 2020	BUY	$15.87 - $23.12 $594,188 - $865,635	37,441 Added 13.45%	315,728 $6.82 Million
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $3.7 Million - $7.93 Million	218,613 Added 366.35%	278,287 $5.07 Million
Q2 2019 Aug 09, 2019	BUY	$31.0 - $36.3 $645,234 - $755,548	20,814 Added 53.56%	59,674 $2.12 Million
Q1 2019 May 13, 2019	SELL	$31.58 - $46.35 $1.02 Million - $1.5 Million	-32,435 Reduced 45.49%	38,860 $1.31 Million
Q4 2018 Feb 06, 2019	SELL	$30.43 - $56.65 $1.6 Million - $2.99 Million	-52,731 Reduced 42.52%	71,295 $2.34 Million
Q3 2018 Nov 08, 2018	SELL	$46.46 - $68.49 $5.49 Million - $8.09 Million	-118,160 Reduced 48.79%	124,026 $7.56 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $4.76 Million - $10.8 Million	102,950 Added 73.94%	242,186 $11.8 Million
Q1 2018 May 11, 2018	BUY	$57.4 - $108.44 $1.51 Million - $2.86 Million	26,393 Added 23.39%	139,236 $14.8 Million
Q4 2017 Feb 09, 2018	BUY	$23.02 - $60.5 $2 Million - $5.25 Million	86,811 Added 333.48%	112,843 $6.74 Million
Q3 2017 Nov 15, 2017	SELL	$17.79 - $24.0 $522,581 - $705,000	-29,375 Reduced 53.02%	26,032 $625,000
Q2 2017 Aug 14, 2017	BUY	N/A	55,407	55,407 $1.08 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Nektar Therapeutics Transaction History